Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

China

 

Medtronic invests in China’s Pulnovo

Pulnovo Medical, a China-based medtech company developing treatments for pulmonary hypertension and heart failure, has raised $100 million in an oversubscribed round led by Medtronic, the world’s largest medtech company.

AstraZeneca plans to invest $15 billion in China

Global pharmaceutical company AstraZeneca is set to make a $15 billion investment in China through 2030 to expand its manufacturing and research and development capabilities in the country.

Bupa Hong Kong expands coverage to 3,600 hospitals in mainland China

Bupa Hong Kong, the Chinese division of multinational health insurer and provider Bupa, is massively expanding its coverage in mainland China, with a new scheme covering 3,600 hospitals across the country. The company is simultaneously expanding coverage to 3,000 ‘service points’ on the island of Hong Kong.

FREE BLOG Standout themes from HBI’s Asia report

We’re about to release a Special Report on healthcare investment in Asia. The report offers a comprehensive overview of the dynamics, trends and opportunities in the healthcare markets of eight hugely important countries in the region: China, India, South Korea, Thailand, Vietnam, Indonesia, Malaysia and the Philippines. 

CVC, KKR and Macquarie shortlisted to acquire minority stake in Luz Saúde

Private equity firms CVC Capital Partners, KKR, and Macquarie, have been shortlisted to compete for a minority stake of Luz Saúde, one of Portugal’s largest private healthcare groups. Fidelidade reportedly intends to sell between 30% and 49% of Luz Saúde, with the receipt of binding offers expected in July, and the deal to close before […]

Bupa Hong Kong expands into mainland China with hospital partnerships

The Hong Kong division of multinational private health insurer and provider Bupa is expanding its direct settlement scheme into mainland China by partnering with four Chinese private hospital groups that operate in the Guangdong–Hong Kong–Macao Greater Bay Area. The move comes after Bupa Group withdrew from the country in 2023, and after the Chinese government decided to open up certain regions to foreign healthcare investment in 2024.

Find Us